Low-Dose Lenalidomide After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation With Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma
Titel:
Low-Dose Lenalidomide After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation With Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma
Auteur:
Khouri, Jack Reu, Frederic Majhail, Navneet S. Gerds, Aaron Jagadeesh, Deepa Dean, Robert Sobecks, Ronald Hamilton, Betty K. Pohlman, Brad Hill, Brian T. Corrigan, Donna Kalaycio, Matt Bolwell, Brian J. Liu, Hien D.